Supernus Pharmaceuticals, Inc. (SUPN)

48.21 -1.17 (-2.37%) USD  |  NASDAQ  |  May 22, 16:00
48.20 -0.01 (-0.02%) After-Hours: 20:00
More

Supernus Pharmaceuticals EBITDA (Quarterly)

EBITDA (Quarterly) Chart

View EBITDA (Quarterly) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly) Range, Past 5 Years

View EBITDA (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly) Benchmarks

View EBITDA (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Amphastar Pharmaceuticals, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade